Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
Cancer Immunology Research|February 19, 2022
Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell-Mediated Antitumor Immune ResponsesAndrew Fedoriw, Leilei Shi, Shane O'Brien, et al.
Cell Reports. Medicine|December 3, 2024
UBA1 inhibition sensitizes cancer cells to PARP inhibitorsSharad Awasthi, Lacey E Dobrolecki, Christina Sallas, et al.
Journal for Immunotherapy of Cancer|February 16, 2021
Integrating genome-wide CRISPR immune screen with multi-omic clinical data reveals distinct classes of tumor intrinsic immune regulatorsJiakai Hou, Yunfei Wang, Leilei Shi, et al.
Nature Communications|January 3, 2024
Integrated multi-omics analyses identify anti-viral host factors and pathways controlling SARS-CoV-2 infectionJiakai Hou, Yanjun Wei, Jing Zou, et al.
Journal for Immunotherapy of Cancer|April 1, 2025
IL-12-producing cytokine factories induce precursor exhausted T cells and elimination of primary and metastatic tumorsAmanda Nash, Jonathon DeBonis, Danna Murungi, et al.
Nature Medicine|March 5, 2013
Persistent antigen at vaccination sites induces tumor-specific CD8⁺ T cell sequestration, dysfunction and deletionYared Hailemichael, Zhimin Dai, Nina Jaffarzad, et al.
The Journal of Investigative Dermatology|March 5, 2023
Multiplatform Analysis of Intratumoral PTEN Heterogeneity in MelanomaSharmeen Chagani, Mariana P De Macedo, Fernando Carapeto, et al.
Biorxiv : the Preprint Server for Biology|May 4, 2026
Acquired resistance to the PRMT5 inhibitor confers collateral sensitivity to MEK inhibition in MTAP-null non-small cell lung cancerRongjie Fu, Yalong Wang, Ishita Rehman, et al.
Leukemia|April 28, 2019
CXCR5+CD8+ T cells are a distinct functional subset with an antitumor activityFuliang Chu, Haiyan S Li, Xindong Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2019
Anti-OX40 Antibody Directly Enhances The Function of Tumor-Reactive CD8+ T Cells and Synergizes with PI3Kβ Inhibition in PTEN Loss MelanomaWeiyi Peng, Leila J Williams, Chunyu Xu, et al.
Pageof 8